Literature DB >> 7908284

Immunosuppressive effect of shedding intercellular adhesion molecule 1 antigen on cell-mediated cytotoxicity against tumor cells.

S Koyama1.   

Abstract

We have examined whether shedding intercellular adhesion molecule-1 (ICAM-1) antigen from cultured tumors is able to inhibit the leukocyte function-associated antigen-1 (LFA-1)/ICAM-1 interaction between cytotoxic effector cells and ICAM-1+ target tumor cells. The cytotoxic activity of lymphokine-activated killer (LAK) cells incubated with spent media from ICAM-1+ tumor cells, especially interferon-gamma-stimulated tumor cells, was significantly decreased as compared with that of LAK cells treated with fresh culture medium without ICAM-1 antigen. Treatment of LAK cells with spent media from ICAM-1- tumor cells did not cause a significant decrease of the cytolytic activity towards ICAM-1+ tumor cells. These findings suggest that shedding of ICAM-1 antigen could be involved in binding of LFA-1 to LAK cells, resulting in reduced cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908284      PMCID: PMC5919416          DOI: 10.1111/j.1349-7006.1994.tb02072.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Antigen shedding vs. development of natural suppressor cells as mechanism of tumor escape in mice bearing Ehrlich tumor.

Authors:  J E Viñuela; R Rodriguez; J Gil; J Coll; E G De la Concha; J L Subiza
Journal:  Int J Cancer       Date:  1991-01-02       Impact factor: 7.396

2.  Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.

Authors:  J Koide; E G Engleman
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

3.  Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells.

Authors:  L T Clement; M K Dagg; A Landay
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

4.  Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.

Authors:  S Koyama; T Ebihara; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Escape mechanisms of melanoma from immune system by soluble melanoma antigen.

Authors:  K Takahashi; K Ono; Y Hirabayashi; M Taniguchi
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

6.  Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses.

Authors:  Y Tomita; T Nishiyama; H Watanabe; M Fujiwara; S Sato
Journal:  Int J Cancer       Date:  1990-12-15       Impact factor: 7.396

7.  Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma.

Authors:  S Koyama; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.

Authors:  P Natali; M R Nicotra; R Cavaliere; A Bigotti; G Romano; M Temponi; S Ferrone
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

9.  Suppression by sorted CD8+CD11b- cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma.

Authors:  T Ebihara; N Sakai; S Koyama
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

10.  Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.

Authors:  S Koyama; T Ebihara; K Fukao; T Osuga
Journal:  Jpn J Cancer Res       Date:  1989-02
View more
  4 in total

1.  Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

Authors:  M D'Angelica; C Tung; P Allen; M Halterman; K Delman; T Delohery; D Klimstra; M Brownlee; H Federoff; Y Fong
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

2.  Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration.

Authors:  Z Dong; S Fu; X Xu; Y Yang; L Du; W Li; S Kan; Z Li; X Zhang; L Wang; J Li; H Liu; X Qu; C Wang
Journal:  Br J Cancer       Date:  2014-02-18       Impact factor: 7.640

3.  E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.

Authors:  Zijia Ren; Wenyao Kang; Lihua Wang; Baoliang Sun; Jiajia Ma; Chaogu Zheng; Jie Sun; Zhigang Tian; Xiaoyi Yang; Weihua Xiao
Journal:  Mol Cancer       Date:  2014-04-17       Impact factor: 27.401

Review 4.  Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.

Authors:  Gustavo Rodrigues Rossi; Edvaldo S Trindade; Fernando Souza-Fonseca-Guimaraes
Journal:  Front Immunol       Date:  2020-01-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.